FI922268A0 - Menetelmä uusien terapeuttisesti käyttökelpoisten N-difenyylialkyylialkoksisubstituoitujen 3-piperidiinikarboksyylihappojohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten N-difenyylialkyylialkoksisubstituoitujen 3-piperidiinikarboksyylihappojohdannaisten valmistamiseksi

Info

Publication number
FI922268A0
FI922268A0 FI922268A FI922268A FI922268A0 FI 922268 A0 FI922268 A0 FI 922268A0 FI 922268 A FI922268 A FI 922268A FI 922268 A FI922268 A FI 922268A FI 922268 A0 FI922268 A0 FI 922268A0
Authority
FI
Finland
Prior art keywords
substituted
image
diphenylalkylalkoxy
preparation
acid derivatives
Prior art date
Application number
FI922268A
Other languages
English (en)
Swedish (sv)
Other versions
FI97541B (fi
FI97541C (fi
FI922268A (fi
Inventor
Knud Erik Andersen
Lars Jacob Stray Knudsen
Ursula Sonnewald
Per Olaf Soerensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI922268A0 publication Critical patent/FI922268A0/fi
Publication of FI922268A publication Critical patent/FI922268A/fi
Publication of FI97541B publication Critical patent/FI97541B/fi
Application granted granted Critical
Publication of FI97541C publication Critical patent/FI97541C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyridine Compounds (AREA)
FI922268A 1989-11-22 1992-05-19 Menetelmä uusien terapeuttisesti käyttökelpoisten N-difenyylialkyylialkoksisubstituoitujen 3-piperidiinikarboksyylihappojohdannaisten valmistamiseksi FI97541C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK588189 1989-11-22
DK588189A DK588189D0 (da) 1989-11-22 1989-11-22 Nye heterocykliske carboxylsyrer
PCT/DK1990/000302 WO1991007389A1 (en) 1989-11-22 1990-11-22 N-substituted azaheterocyclic carboxylic acids and a pharmaceutical composition
DK9000302 1990-11-22

Publications (4)

Publication Number Publication Date
FI922268A0 true FI922268A0 (fi) 1992-05-19
FI922268A FI922268A (fi) 1992-05-19
FI97541B FI97541B (fi) 1996-09-30
FI97541C FI97541C (fi) 1997-01-10

Family

ID=8145900

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922268A FI97541C (fi) 1989-11-22 1992-05-19 Menetelmä uusien terapeuttisesti käyttökelpoisten N-difenyylialkyylialkoksisubstituoitujen 3-piperidiinikarboksyylihappojohdannaisten valmistamiseksi

Country Status (16)

Country Link
US (1) US5198451A (fi)
EP (1) EP0502031B1 (fi)
JP (1) JPH05503083A (fi)
AT (1) ATE157086T1 (fi)
AU (1) AU660919B2 (fi)
CA (1) CA2073189C (fi)
DE (1) DE69031312T2 (fi)
DK (2) DK588189D0 (fi)
FI (1) FI97541C (fi)
IE (1) IE904155A1 (fi)
IL (2) IL96370A0 (fi)
NO (1) NO177853C (fi)
NZ (1) NZ236155A (fi)
PT (1) PT95970B (fi)
WO (1) WO1991007389A1 (fi)
ZA (1) ZA909305B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK74693D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
JP2000511538A (ja) * 1996-05-24 2000-09-05 スミスクライン・ビーチャム・コーポレイション 鎮咳剤としてのgaba取り込み阻害剤の使用
DE10204496A1 (de) * 2002-02-04 2003-08-21 Msa Auer Gmbh Vorrichtung zur Dosierung gas- und/oder dampfförmiger Stoffe

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
FI864246A (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
US4772615A (en) * 1985-11-08 1988-09-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
ES2059360T3 (es) * 1986-01-07 1994-11-16 Novo Nordisk As Nuevos derivados de aminoacidos.
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents

Also Published As

Publication number Publication date
DK588189D0 (da) 1989-11-22
NZ236155A (en) 1993-04-28
CA2073189C (en) 1998-04-07
DE69031312D1 (de) 1997-09-25
EP0502031B1 (en) 1997-08-20
NO177853C (no) 1995-12-06
PT95970B (pt) 1998-01-30
DK0502031T3 (da) 1998-03-30
ZA909305B (en) 1991-09-25
IL96370A (en) 1995-01-24
US5198451A (en) 1993-03-30
NO921852L (no) 1992-05-11
FI97541B (fi) 1996-09-30
FI97541C (fi) 1997-01-10
WO1991007389A1 (en) 1991-05-30
AU6746490A (en) 1991-06-13
NO921852D0 (no) 1992-05-11
FI922268A (fi) 1992-05-19
IL96370A0 (en) 1991-08-16
EP0502031A1 (en) 1992-09-09
AU660919B2 (en) 1995-07-13
ATE157086T1 (de) 1997-09-15
PT95970A (pt) 1991-09-13
JPH05503083A (ja) 1993-05-27
DE69031312T2 (de) 1998-02-26
IE904155A1 (en) 1991-05-22
CA2073189A1 (en) 1991-05-23
NO177853B (no) 1995-08-28

Similar Documents

Publication Publication Date Title
FI882176A0 (fi) Menetelmä terapeuttisesti aktiivisten heterosyklisten peptidien valmistamiseksi ja niiden valmistuksessa käyttökelpoisia välituotteita
NO175256C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 4-oksokinolin-3-karboksylsyrederivater
ATE220402T1 (de) Basisch substituierte vinylpyrrolidin- cephalosporine
GR3032220T3 (en) Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation
DK390587A (da) 7-oeoe3-aminomethyl-3-alkylaa-1-pyrrolidinylaa-quino lin-carboxylsyre
JP2005504729A5 (fi)
FI922268A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten N-difenyylialkyylialkoksisubstituoitujen 3-piperidiinikarboksyylihappojohdannaisten valmistamiseksi
FI101301B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi
HUT67695A (en) 4-[(2-benzothiazolyl)-methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperedineethanol, pharmaceutical compositions containing that and process for preparing them
PT1021404E (pt) Derivados de azetidinona para o tratamento de infeccoes pelo hcmv
ATE116974T1 (de) 5- piperazinylalkyl-1,5-benzothiazepinone verwendbar als calciumantagonisten.
ES2067635T3 (es) Derivados heterociclicos de beta-aminoacidos acilaminodiolicos.
ATE212637T1 (de) Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung
FI895568A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminodiolijohdannaisten valmistamiseksi
KR960704888A (ko) AMPA-수용체에 작용하는 알콕시-치환 β-카르보린 (Alkoxy-Substituted β-Carbolines Acting on The AMPA-Receptor)
NZ331180A (en) Specific immunophilin ligands with indole structure as antiasthmatics and immunosuppressants
DE68914309D1 (de) Verfahren zur Herstellung von Phtalazinessigsäure-Ester-Derivaten und ein neues Zwischenprodukt.
DE50000905D1 (de) Verfahren zur Herstellung von N-Acyl-aminosäureestern und N-Acyl-aminoacetalen
FI962714A (fi) Menetelmä terapeuttisesti käyttökelpoisten naftyridiinijohdannaisten valmistamiseksi
UY23774A1 (es) Procedimiento para la preparacion de pirroles sustituidos

Legal Events

Date Code Title Description
BB Publication of examined application